Theriva BiologicsTOVX
13F holders, Q1 2026 (March 31)22holders +1
3new positions
3sold out
$0.20avg. 13F price*
At the end of Q1 2026, 22 institutions reported holding Theriva Biologics Inc. (TOVX) in their 13F filings, up 1 from Q4 2025. 3 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($88K), Virtu Financial LLC ($50K) and Vanguard Fiduciary Trust Co. ($47K).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $85K |
| Exits | 3 | $22K |
All 13F filers, Q4 2025 → Q1 2026: 820,238 shares bought and 328,922 shares sold, net +491,316 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Geode Capital Management, LLC | 0.00% | Add +112.3% | 450,263 | $88K |
| Virtu Financial LLC | 0.00% | New | 253,218 | $50K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 241,780 | $47K |
| UBS Group AG | 0.00% | Add +17.9% | 225,624 | $44K |
| Vanguard Capital Management LLC | 0.00% | — | 192,404 | $38K |
| Jane Street Group, LLC | 0.00% | New | 177,034 | $35K |
| Ikarian Capital, LLC | 0.00% | No change | 112,076 | $22K |
| Two Sigma Securities, LLC | 0.00% | Add +145.4% | 105,241 | $21K |
| XTX Topco Ltd | 0.00% | Add +139.9% | 94,620 | $19K |
| Boothbay Fund Management, LLC | 0.00% | No change | 27,646 | $5K |
| Morgan Stanley | 0.00% | Reduce -88.2% | 23,602 | $5K |
| StoneX Group Inc. | 0.00% | Reduce -40.1% | 22,280 | $4K |
| Two Sigma Investments, LP | 0.00% | Reduce -63.5% | 15,441 | $3K |
| Schwarz Dygos Wheeler Investment Advisors LLC | 0.00% | No change | 15,000 | $3K |
| BlackRock, Inc. | 0.00% | No change | 7,504 | $1K |
| Citigroup Inc. | 0.00% | Reduce -77.5% | 1,391 | $272 |
| SBI Securities Co., Ltd. | 0.00% | Add +122.0% | 131 | $26 |
| IFP Advisors, Inc | 0.00% | No change | 11 | $2 |
| Osaic Holdings, Inc. | 0.00% | Reduce -98.2% | 8 | $1 |
| NFSG Corp | 0.00% | No change | 5 | $1 |
| Danske Bank A/S | 0.00% | No change | 1 | $0 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is TOVX's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.